[ad_1]
India, second in crown 19 confirmed accumulated cases, approved the emergency use of two vaccines
AstraZeneca vaccine, vaccine from the native company Barat Biotech
Serum Institute, AstraZeneca vaccine clinical trial
[앵커]
Two national vaccines were approved in India, where the second highest number of corona19 was confirmed after the US. In Russia, which has already vaccinated 800,000 domestic vaccines, electronic vaccination certificates have been issued. Reporter Yeojin Lee reports. India, with more than 10 million cumulative confirmed cases of corona19, has officially announced approval for the urgent use of two vaccines. It is the UK AstraZeneca vaccine ‘Coby Shield’ produced by local vaccine company Serum Institute, and ‘Cobaxine’ developed by local company Barat Biotech. Serum Institute, an Indian pharmaceutical company, the largest vaccine company in the world, conducted a clinical trial of the AstraZeneca vaccine. In addition, 50 million doses of vaccine have already been produced so that they can be distributed immediately after approval. Indian Prime Minister Narendra Modi wrote a congratulatory message: “The approval of the vaccine will be a decisive turning point in the fight against COVID-19.” The priority vaccination targets are around 300 million people, including medical personnel, police, soldiers, and the elderly aged 50 and over. Russia, which has previously started vaccinating its own production, says more than 800,000 people have been vaccinated with Sputnik V. Russia launched a large-scale vaccination of the public in early December last year. In addition, people who received vaccines in Russia received electronic vaccination certificates through public service sites from the 1st. Vaccines from countries with vaccines are gaining momentum as they accelerate their vaccinations from Russia and China to India. This is YTN Lee Yeo-jin.
